NCT05032066 A Multicenter Trial to Evaluate the Efficacy, Safety and Tolerability of HZN-825 in Subjects With Idiopathic Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT05022784 Adherence to Nintedanib Among Idiopathic Pulmonary Fibrosis Patients Status COMPLETED Phase N/A
NCT05022771 A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of PMG1015 Status COMPLETED Phase PHASE1
NCT05016817 Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF Status RECRUITING Phase PHASE1
NCT04968574 A Study Evaluating the Safety and Efficacy of ENV-101 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT04965298 Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole Status RECRUITING Phase PHASE3
NCT04931147 A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04905693 Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease Status ENROLLING_BY_INVITATION Phase PHASE3
NCT04888728 To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04888715 To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT04803617 Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease Status COMPLETED Phase N/A
NCT04767815 To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT04720443 A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects Status COMPLETED Phase PHASE1
NCT04708782 Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT04693975 Social Distancing During the COVID-19 Pandemic and People Living With Chronic Respiratory Diseases Status UNKNOWN Phase N/A